Influences on Technology Use and Efficacy in Type 1 Diabetes

Journal of Diabetes Science and Technology

Volumn 10, Issue 3, 2016, Pages 647-655

  Franklin, Victoria ^a,b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

closed loop technology; insulin pumps; psychology; technology; type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; ASSESSMENT OF HUMANS; BLOOD GLUCOSE MONITORING; HUMAN; HYPERGLYCEMIA; HYPOGLYCAEMIA FEAR SURVEY WORRY AND BEHAVIOUR SUBSCALE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL PROCEDURES; MEDICAL TECHNOLOGY; PATIENT SATISFACTION; QUALITY OF LIFE; SELF CARE; SENSOR AUGMENTED PUMP THERAPY; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; ATTITUDE TO HEALTH; BLOOD; DEVICES; FEMALE; INSULIN INFUSION; MALE; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INSULIN INFUSION SYSTEMS; MALE; PATIENT EDUCATION AS TOPIC; SELF CARE;

EID: 85009508833     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816639315     Document Type: Article

References (119)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329 (14): 977-986.
2. McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015; 32 (8): 1036-1050.
3. Rewers MJ, Pillay K, de Beaufort C, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014; 15 (suppl 20): 102-114.
4. American Diabetes Association. Executive summary: standards of medical care in diabetes-2014. Diabetes Care. 2014; 37 (suppl 1): S5-S13.
5. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013; 36 (7): 2009-2014.
6. Hansen MV, Pedersen-Bjergaard U, Heller SR, et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract. 2009; 85 (2): 183-188.
7. Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV., Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000; 23 (4): 477-483.
8. Fisher WA,. Barriers and behaviors in blood glucose monitoring. Touch Briefings. 2007: 51.
9. Ingerski LM, Anderson BJ, Dolan LM, Hood KK., Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflict. J Adolesc Health. 2010; 47 (2): 191-197.
10. Helgeson VS, Honcharuk E, Becker D, Escobar O, Siminerio L., A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency. Pediatr Diabetes. 2011; 12 (1): 25-30.
11. Delamater AM, Jacobson AM, Anderson B, et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care. 2001; 24 (7): 1286-1292.
12. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L., Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997; 130 (2): 257-265.
13. Haugstvedt A, Wentzel-Larsen T, Rokne B, Graue M., Psychosocial family factors and glycemic control among children aged 1-15 years with type 1 diabetes: a population-based survey. BMC Pediatr. 2011; 11:118,2431-11-118.
14. Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ., Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study. BMC Pub Health. 2012; 12:167,2458-12-167.
15. Snoek F, Malanda U, de Wit M., Self-monitoring of blood glucose: psychological barriers and benefits. EDN. 2008; 5 (3): 112-115.
16. Kerr D., Poor numeracy: the elephant in the diabetes technology room. J Diabetes Sci Technol. 2010; 4 (6): 1284-1287.
17. Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36 (11): 3613-3619.
18. Barnard K, Parkin C, Young A, Ashraf M., Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diabetes Sci Technol. 2012; 6 (1): 144-149.
19. Rabbone I, Scaramuzza AE, Ignaccolo MG, et al. Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study. Diabetes Res Clin Pract. 2014; 103 (3): 388-394.
20. Schmidt S, Meldgaard M, Serifovski N, et al. Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study. Diabetes Care. 2012; 35 (5): 984-990.
21. Lawton J, Kirkham J, Rankin D, et al. Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation. Diabetes Res Clin Pract. 2014; 106 (3): 443-450.
22. Monami M, Lamanna C, Marchionni N, Mannucci E., Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol. 2010; 47 (suppl 1): 77-81.
23. Pickup JC, Sutton AJ., Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008; 25 (7): 765-774.
24. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R., Insulin pump therapy: a meta-analysis. Diabetes Care. 2003; 26 (4): 1079-1087.
25. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H., Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009; 10 (1): 52-58.
26. Knight S, Northam E, Donath S, et al. Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia. 2009; 52 (2): 193-198.
27. Knight SJ, Northam EA, Cameron FJ, Ambler GR., Behaviour and metabolic control in children with type 1 diabetes mellitus on insulin pump therapy: 2-year follow-up. Diabet Med. 2011; 28 (9): 1109-1112.
28. Klonoff DC, Reyes JS., Insulin pump safety meeting: summary report. J Diabetes Sci Technol. 2009; 3 (2): 396-402.
29. Grunberger G, Abelseth JM, Bailey TS, et al. Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force. Endocr Pract. 2014; 20 (5): 463.
30. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV., Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999; 22 (11): 1779-1784.
31. Weiss R, Garg SK, Bode BW, et al. Hypoglycemia reduction and changes in hemoglobin A1c in the ASPIRE In-Home Study. Diabetes Technol Ther. 2015; 17 (8): 542-547.
32. Rankin D, Harden J, Noyes K, Waugh N, Barnard K, Lawton J., Parents' experiences of managing their child's diabetes using an insulin pump: a qualitative study. Diabet Med. 2015; 32 (5): 627-634.
33. Muller-Godeffroy E, Treichel S, Wagner VM, German Working Group for Paediatric Pump Therapy. Investigation of quality of life and family burden issues during insulin pump therapy in children with type 1 diabetes mellitus-a large-scale multicentre pilot study. Diabet Med. 2009; 26 (5): 493-501.
34. Todres L, Keen S, Kerr D,. Continuous subcutaneous insulin infusion in type 1 diabetes: patient experiences of "living with a machine." Diabet Med. 2010; 27 (10): 1201-1204.
35. Alsaleh FM, Smith FJ, Taylor KM., Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review. J Clin Pharm Ther. 2012; 37 (2): 140-147.
36. Alsaleh FM, Smith FJ, Thompson R, Al-Saleh MA, Taylor KM., Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents. Int J Clin Pharm. 2014; 36 (5): 1023-1030.
37. Juvenile Diabetes Research Federation, Diabetes Australia. Phase 2: review of the clinical benefits of insulin pump therapy for type 1 diabetes. 2013.
38. Ritholz MD, Smaldone A, Lee J, Castillo A, Wolpert H, Weinger K., Perceptions of psychosocial factors and the insulin pump. Diabetes Care. 2007; 30 (3): 549-554.
39. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M., Predictors of glycaemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med. 2010; 27 (3): 339-347.
40. Wilkinson J, McFann K, Chase HP., Factors affecting improved glycaemic control in youth using insulin pumps. Diabet Med. 2010; 27 (10): 1174-1177.
41. Hine P, Senniappan S, Sankar V, Amin R., Deprivation impedes success of insulin intensification in children and adolescents with type 1 diabetes; longitudinal linear mixed modelling of a retrospective observational cohort. Diabet Med. 2011; 28 (3): 338-344.
42. Lin MH, Connor CG, Ruedy KJ, et al. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013; 15 (11): 929-934.
43. Cortina S, Repaske DR, Hood KK., Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes. Pediatr Diabetes. 2010; 11 (5): 337-344.
44. Aberle I, Scholz U, Bach-Kliegel B, et al. Psychological aspects in continuous subcutaneous insulin infusion: a retrospective study. J Psychol. 2009; 143 (2): 147-160.
45. Hofer SE, Heidtmann B, Raile K, et al. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria. Pediatr Diabetes. 2010; 11 (2): 116-121.
46. Binek MA, Rembierz-Knoll A, Polanska J, Jarosz-Chobot P,. The reasons for pump discontinuation in children with diabetes type 1 (T1DM). Pediatr Diabetes. 2013: 46.
47. Norgaard K, Scaramuzza A, Bratina N, et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther. 2013; 15 (4): 273-280.
48. Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55 (12): 3155-3162.
49. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363 (4): 311-320.
50. Hermanides J, Norgaard K, Bruttomesso D, et al. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled type 1 diabetes; a randomized controlled trial. Diabet Med. 2011; 28 (10): 1158-1167.
51. Hirsch IB, Abelseth J, Bode BW, et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008; 10 (5): 377-383.
52. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359 (14): 1464-1476.
53. Juvenile Diabetes Research Foundation Continuous Glucose MonitoringStudy Group, Beck RW, Buckingham B, et al. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009; 32 (11): 1947-1953.
54. Schmidt S, Duun-Henriksen AK, Norgaard K., Psychosocial factors and adherence to continuous glucose monitoring in type 1 diabetes. J Diabetes Sci Technol. 2012; 6 (4): 986-987.
55. Tansey M, Laffel L, Cheng J, et al. Satisfaction with continuous glucose monitoring in adults and youths with type 1 diabetes. Diabet Med. 2011; 28 (9): 1118-1122.
56. Glowinska-Olszewska B, Tobiaszewska M, Luczynski W, Bossowski A., Monthly use of a real-time continuous glucose monitoring system as an educational and motivational tool for poorly controlled type 1 diabetes adolescents. Adv Med Sci. 2013; 58 (2): 344-352.
57. Rubin RR, Peyrot M., Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. J Diabetes Sci Technol. 2009; 3 (6): 1402-1410.
58. Rubin RR, Peyrot M, STAR 3 Study Group. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetes Technol Ther. 2012; 14 (2): 143-151.
59. Norgaard K, Scaramuzza A, Bratina N, et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther. 2013; 15 (4): 273-280.
60. Jenkins AJ, Krishnamurthy B, Best JD, et al. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care. 2010; 33 (6): 1242-1248.
61. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Lawrence JM, et al. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care. 2010; 33 (10): 2175-2177.
62. Ritholz MD, Atakov-Castillo A, Beste M, et al. Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med. 2010; 27 (9): 1060-1065.
63. Hommel E, Olsen B, Battelino T, et al. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol. 2014; 51 (5): 845-851.
64. Danne T, Lange K, Kordonouri O., Real-time glucose sensors in children and adolescents with type-1 diabetes. Horm Res. 2008; 70 (4): 193-202.
65. Markowitz JT, Pratt K, Aggarwal J, Volkening LK, Laffel LM., Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth. Diabetes Technol Ther. 2012; 14 (6): 523-526.
66. Barnard K, Thomas S, Royle P, Noyes K, Waugh N., Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr. 2010; 10:50,2431-10-50.
67. Landau Z, Rachmiel M, Pinhas-Hamiel O, et al. Parental sleep quality and continuous glucose monitoring system use in children with type 1 diabetes. Acta Diabetol. 2014; 51 (3): 499-503.
68. Agrawal P, Zhong A, Welsh JB, Shah R, Kaufman FR., Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther. 2015; 17 (5): 316-319.
69. Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011; 13 (11): 1129-1134.
70. Messer L, Ruedy K, Xing D, et al. Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience. Diabetes Educ. 2009; 35 (1): 124-135.
71. Dassau E, Atlas E, Phillip M., Closing the loop. Int J Clin Pract Suppl. 2011;(170): 20-25.
72. Hovorka R., Artificial pancreas project at Cambridge 2013. Diabet Med. 2015; 32 (8): 987-992.
73. van Bon AC, Kohinor MJ, Hoekstra JB, von Basum G, deVries JH., Patients' perception and future acceptance of an artificial pancreas. J Diabetes Sci Technol. 2010; 4 (3): 596-602.
74. Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care. 2014; 37 (11): 3025-3032.
75. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013; 368 (9): 824-833.
76. Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol. 2014; 2 (9): 701-709.
77. Breton M, Farret A, Bruttomesso D, et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012; 61 (9): 2230-2237.
78. Barnard KD, Wysocki T, Allen JM, et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014; 2 (1): e000025.
79. Hampson SE, Skinner TC, Hart J, et al. Behavioral interventions for adolescents with type 1 diabetes: how effective are they? Diabetes Care. 2000; 23 (9): 1416-1422.
80. Fjeldsoe BS, Marshall AL, Miller YD., Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009; 36 (2): 165-173.
81. McNamara JPH, Reid AM, Freedland AR, Righi SE, Geffken GR,. Contributing factors to poor adherence and glycemic control in pediatric type 1 diabetes: facilitating a move toward telehealth. In: Liu CP, ed. Type 1 Diabetes-Pathogenesis, Complications and Alternative Treatments. Rijeka, Croatia: In-Tech; 2011: 141-158.
82. Pagliari C, Sloan D, Gregor P, et al. What is eHealth (4): a scoping exercise to map the field. J Med Internet Res. 2005; 7 (1): e9.
83. Balkhi AM, Reid AM, Westen SC, Olsen B, Janicke DM, Geffken GR., Telehealth interventions to reduce management complications in type 1 diabetes: A review. World J Diabetes. 2015; 6 (3): 371-379.
84. El-Gayar O, Timsina P, Nawar N, Eid W., A systematic review of IT for diabetes self-management: are we there yet? Int J Med Inform. 2013; 82 (8): 637-652.
85. Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L., Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol. 2010; 4 (3): 666-684.
86. Liang X, Wang Q, Yang X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011; 28 (4): 455-463.
87. Webb TL, Joseph J, Yardley L, Michie S., Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res. 2010; 12 (1): e4.
88. Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM., Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care. 2000; 23 (6): 765-769.
89. Fisher WA, Cornman DH, Kohut TSH, Stenger P., What primary care providers can do to address barriers to self-monitoring of blood glucose. Clin Diabetes. 2013; 31 (1): 34.
90. Kocher S, Tshiananga JK, Koubek R., Comparison of lancing devices for self-monitoring of blood glucose regarding lancing pain. J Diabetes Sci Technol. 2009; 3 (5): 1136-1143.
91. Tieszen KL, New JP., Alternate site blood glucose testing: do patients prefer it? Diabet Med. 2003; 20 (4): 325-328.
92. Ito T, Kamoi K, Minagawa S, Kimura K, Kobayashi A., Patient perceptions of different lancing sites for self-monitoring of blood glucose: a comparison of fingertip site with palm site using the OneTouch Ultra Blood Glucose Monitoring System. J Diabetes Sci Technol. 2010; 4 (4): 906-910.
93. Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S., The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015; 17 (11): 787-794.
94. Moreland EC, Volkening LK, Lawlor MT, Chalmers KA, Anderson BJ, Laffel LM., Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch Intern Med. 2006; 166 (6): 689-695.
95. Choudhary P, Genovese S, Reach G., Blood glucose pattern management in diabetes: creating order from disorder. J Diabetes Sci Technol. 2013; 7 (6): 1575-1584.
96. Baron J, McBain H, Newman S., The impact of mobile monitoring technologies on glycosylated hemoglobin in diabetes: a systematic review. J Diabetes Sci Technol. 2012; 6 (5): 1185-1196.
97. Kerr D, Messing R, Resch A., Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy. J Diabetes Sci Technol. 2011; 5 (6): 1584-1590.
98. Colin IM, Paris I., Glucose meters with built-in automated bolus calculator: gadget or real value for insulin-treated diabetic patients? Diabetes Ther. 2013; 4 (1): 1-11.
99. Phillip M, Danne T, Shalitin S, et al. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes. 2012; 13 (3): 215-228.
100. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002; 287 (19): 2563-2569.
101. Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre LWN,. Clinical effectiveness and cost-effectiveness of CSII for diabetes: systematic review and economic evaluation. Health Technol Assess. 2010; 14: 1-228.
102. Lawton J, Kirkham J, Rankin D, et al. Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial. Diabet Med. 2016; 33 (2): 243-251.
103. Cavanaugh K, Wallston KA, Gebretsadik T, et al. Addressing literacy and numeracy to improve diabetes care: two randomized controlled trials. Diabetes Care. 2009; 32 (12): 2149-2155.
104. Randell T,. Paediatric best practice tariff criteria. 2011. Available at: https://www.diabetes.org.uk/Documents/nhs-diabetes/paediatrics/Paediatric%20Diabetes%20Best%20Practice%20Tariff%20Criteria.pdf. Accessed March 9, 2016.
105. Jefferson IG, Swift PG, Skinner TC, Hood GK., Diabetes services in the UK: third national survey confirms continuing deficiencies. Arch Dis Child. 2003; 88 (1): 53-56.
106. Psychology Working Group for the Scottish Diabetes Group. Review of psychological provision to adults and children with diabetes in Scotland. 2006. Available at: http://www.diabetesinscotland.org.uk/publications/sdg%20psychology%20report%202006.pdf. Accessed March 9, 2016.
107. Neylon OM, O'Connell MA, Skinner TC, Cameron FJ., Demographic and personal factors associated with metabolic control and self-care in youth with type 1 diabetes: a systematic review. Diabetes Metab Res Rev. 2013; 29 (4): 257-272.
108. Wu YP, Rausch J, Rohan JM, et al. Autonomy support and responsibility-sharing predict blood glucose monitoring frequency among youth with diabetes. Health Psychol. 2014; 33 (10): 1224-1231.
109. Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ., Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr. 2003; 142 (4): 409-416.
110. Liberman A, Phillip M, Buckingham B., Diabetes technology and the human factor. Diabetes Technol Ther. 2015; 17 (suppl 1): S109-S118.
111. Mitchell K, Johnson K, Cullen K, Lee MM, Hardy OT., Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes. Diabetes Technol Ther. 2013; 15 (7): 591-595.
112. O'Neal DN, Adhya S, Jenkins A, Ward G, Welsh JB, Voskanyan G., Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set. J Diabetes Sci Technol. 2013; 7 (2): 381-388.
113. Matuleviciene V, Joseph JI, Andelin M, et al. A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther. 2014; 16 (11): 759-767.
114. Chamberlain JJ, Gilgen E., Do perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2015; 9 (1): 105-110.
115. Kaiserman K, Buckingham BA, Prakasam G, et al. Acceptability and utility of the mySentry remote glucose monitoring system. J Diabetes Sci Technol. 2013; 7 (2): 356-361.
116. Kumar VS, Wentzell KJ, Mikkelsen T, Pentland A, Laffel LM., The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes. Diabetes Technol Ther. 2004; 6 (4): 445-453.
117. Klingensmith GJ, Aisenberg J, Kaufman F, et al. Evaluation of a combined blood glucose monitoring and gaming system (Didget(R)) for motivation in children, adolescents, and young adults with type 1 diabetes. Pediatr Diabetes. 2013; 14 (5): 350-357.
118. El-Gayar O, Timsina P, Nawar N, Eid W., Mobile applications for diabetes self-management: status and potential. J Diabetes Sci Technol. 2013; 7 (1): 247-262.
119. Klonoff DC., The current status of mHealth for diabetes: will it be the next big thing? J Diabetes Sci Technol. 2013; 7 (3): 749-758.